Comprehensive In Vitro Proarrhythmia Assay (CiPA) Meeting
May 21-22, 2018
The Cardiac Safety Research Consortium is dedicated to advancing scientific knowledge on cardiac safety for new and existing medical products by building a collaborative environment based upon the principles of the FDA’s Critical Path Initiative as well as other public health priorities.
Save the Date!
Join the CSRC, Health and Environmental Sciences Institute (HESI), and the FDA May 21-22 for a two-day meeting titled, "New Advances in the Assessment of Drug-Induced Arrhythmias and the Comprehensive In Vitro Proarrythmia Assay (CiPA)." Registration information coming soon.
CSRC Members to Present at DIA Annual Meeting
Four CSRC members will represent the consortium at the 2018 Drug Information Association (DIA) Annual Meeting in Boston Sunday and Monday, June 24-25. Find information on the speakers and their topics below:
- June 24:
- Mary Jane Geiger: MD, PhD, FACP: "Real World Evidence Studies to Evaluate the Safety and Effectiveness of Therapeutic Interventions – Is the Data Fit for Purpose and How Will You Know?"
- June 25
- Chair: Rick Turner, DrSc, PhD
- Mitch Krucoff, MD: "The Cardiac Safety Research Consortium: Current Accomplishments and Future Goals"
- Norman Stockbridge, MD, PhD: "New Approaches to Regulatory Science in Cardiac Safety"
- Philip Sager, MD: "The Comprehensive In Vitro Proarrythmia Assay (CiPA)"
We're planning for the following meetings in 2018:
-New Advances in the Assessment of Drug-Induced Arrhythmias and the Comprehensive In Vitro Proarrythmia Assay (CiPA)
-Use of Mobile Technologies in Clinical Trials for Assessment of Cardiovascular Endpoints
-Defining the Clinical and Regulatory Landscape for Cardiogenic Shock
News & Updates
Find us in Cardiology Today!
Learn more about stem cell therapies for cardiovascular diseases in our article published in Cardiology Today.
2017 Report Card Available
Get a recap of 2017 and learn what's in store for 2018 with our 2017 Report Card.
Initiatives and Projects
For more than a decade, we have made great strides in advancing knowledge of cardiac safety in clinical research through conferences, publications, and research projects. We are currently planning for the following think tanks in 2018:
New Advances in the Assessment of Drug-Induced Arrhythmias and the Comprehensive In Vitro Proarrythmia Assay (CiPA) (Spring)
Understanding Cardiogenic Shock and Defining the Concept of “Pre-shock” (Fall)
- Concept of "pre-shock" and develop consensus statements for clinical/research use
- Mechanical circulatory support in treating "pre-shock"
Novel Approaches for the Evaluation of Mobile Technologies in CV Medicine — Scientific rigor, Innovative Methods, Regulatory Acceptance (Fall)
- Integrating devices into supporting cardiovascular safety and efficacy endpoints
- Promised efficiencies of mobile technology in clinical trials
- Device features, patient features, endpoint validation, and regulatory considerations
- Arrhythmia Normal Limits Combined Holter/12 Lead ECG Analysis
- CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study
Submit Your Ideas
SUBMIT YOUR IDEAS FOR THINK TANKS AND PUBLICATIONS
In order to promote the spirit of collaboration the CSRC highly values, we ask that you submit your ideas for future research projects, think tanks, and white papers. By hearing directly from our members, we can ensure that the topics researched, discussed and published are important to you.
CSRC members benefit from engaging in pre-competitive collaboration with cardiac safety professionals on vital research topics and projects. Working together, we have the opportunity to accomplish public health objectives that no single stakeholder could achieve on its own. The CSRC takes to heart the African proverb shared at one of our pediatric safety think tanks:
“If you want to go fast, go alone. If you want to go far, go together.”
In that spirit, we celebrate our second decade of excellence in
cardiac safety research, and going there together.